Stem Cell & Regenerative · Patient guide
Is Vaginal Stem Cell Therapy Proven to Work? An Honest Review
No, vaginal stem cell therapy is not proven to work. The published evidence consists of small studies and case series, mostly without placebo controls, short follow-up and no large randomized trials; any benefit reported is modest and temporary. No major gynecology body recommends it as standard care. Dr. Yoon at Somssi Women's Clinic in Gangnam, Seoul treats it as investigational and recommends proven options such as hormone therapy or surgery when they fit your problem.
Medically reviewed by Dr. Yoon Ho-joo, MD, PhD, OB/GYN specialist, Somssi Women's Clinic · Last updated October 2026
At a glance
Key facts
The essentials, based on how Somssi Women's Clinic performs this procedure or answers this question. Your plan is confirmed at consultation.
- Verdict: Investigational, not proven
- Study quality: Small, often uncontrolled, short follow-up
- Large randomized trials: None to date
- Professional guidelines: No major OB/GYN or urogynecology body recommends it as standard care
- Durability: Any benefit is temporary; repeat sessions are usual
- Proven alternatives: Vaginal estrogen for atrophy; surgical repair for laxity and prolapse
- Reviewed by: Dr. Yoon Ho-joo, MD, PhD, OB/GYN specialist
Vaginal stem cell therapy has not been proven to work; it is an investigational treatment supported only by small, low-quality studies. That does not mean every woman who tries it gets nothing, but it does mean no one can honestly promise you a result, and it should not be sold as a substitute for treatments that have real evidence behind them.
What 'proven' means in medicine
A treatment is considered proven when well-designed trials, ideally randomized and placebo-controlled, show a consistent benefit that outweighs harm, and when independent groups can reproduce the result. For vaginal estrogen in menopausal atrophy, this bar has been met many times. For posterior vaginal repair in laxity and prolapse, decades of surgical literature and textbooks such as Te Linde's Operative Gynecology describe the technique and its outcomes.
Regenerative vaginal injections sit far below that bar. The studies that exist are small, often come from the clinics selling the treatment, rarely include a sham-injection group, and seldom follow women for more than a year.
What the studies actually show
Platelet-rich plasma (PRP)
PRP is the best-studied of the regenerative options, largely because it is cheap and uses the patient's own blood. Pilot studies report improved scores on sexual-function and vaginal-health questionnaires and fewer stress-incontinence episodes in some women over a few months. Where a placebo arm exists, the difference between PRP and placebo is often small. See our O-Shot page for a fuller account.
Fat-derived and cultured stem cells
Reports of injecting fat tissue or laboratory-expanded stem cells into the vaginal wall are mostly case series of a few dozen women or fewer. Outcomes are self-reported, there is no control group, and durability beyond twelve months is unknown. Culture-expanded cells also raise regulatory and safety questions that PRP does not.
Exosomes and growth-factor products
Exosome products are newer still. Evidence for vaginal use is largely laboratory or animal data plus marketing claims; human trials are scarce. In Korea and the United States, no exosome product is approved for injection, which our guide on stem cells versus exosomes explains in detail.
Why the placebo effect matters here
Sexual sensation, arousal and the perception of dryness are strongly influenced by expectation, attention and relationship context. A procedure that involves a consultation, a blood draw, numbing cream and an injection into an intimate area produces a powerful expectation of change. Without a sham-treated comparison group, a study cannot tell whether the injection or the expectation did the work.
This is not a criticism of patients; it is the reason randomized trials exist. It is also why clinics that quote impressive satisfaction percentages from their own uncontrolled data are not giving you proof.
What is proven for the problems people hope to treat
| Problem | Proven or well-established option | Regenerative injection |
|---|---|---|
| Menopausal dryness and thinning | Vaginal estrogen; moisturizers; systemic hormone therapy where suitable | Investigational, possibly modest short-term help |
| Vaginal laxity after childbirth | Pelvic floor training for mild cases; surgical posterior repair for structural laxity | Cannot tighten muscle or shorten the canal |
| Uterine or vaginal prolapse | Pessary or surgical repair, including uterus-preserving hysteropexy | No role |
| Stress urinary incontinence | Pelvic floor training; surgery for persistent cases | Investigational, temporary at best |
| Reduced sensation or orgasm | Sexual-medicine assessment; treat hormonal, medication and relationship factors; repair laxity where present | Investigational |
How Somssi approaches regenerative requests
Somssi Women's Clinic is a surgical gynecology clinic in Gangnam, Seoul, founded in 2000 and led by Dr. Yoon Ho-joo, MD, PhD. Dr. Yoon has published on female sexual function, including a 2005 paper on colpoperineoplasty and sexual function and a 2018 SCI paper on hypoactive sexual desire disorder in 217 Korean women, and has presented at ESSM, WAS, ISSWSH and SMSNA. That background makes us cautious about claims that outrun their data.
In practice we examine first. Vaginal length, width and wall thickness are measured, pelvic floor strength is assessed and the uterus and ovaries are scanned. If the problem is structural, we recommend autologous-tissue vaginoplasty or another repair and explain why an injection would disappoint. If the problem is mucosal or hormonal, we discuss hormone therapy first and regenerative options as a secondary, clearly labeled investigational choice. Our own stem cell offering is an autologous NK immune-cell program given intravenously for immune support; it is not a vaginal treatment.
Questions that separate evidence from marketing
- What exactly is injected, and is it my own blood, my own fat, cultured cells or a manufactured product?
- Is there a published, peer-reviewed study of this product in vaginal tissue with a control group?
- How long did the benefit last in that study, and how many women were followed?
- Is the product approved by the Korean Ministry of Food and Drug Safety for this use?
- What happens if it does not work, and what would you recommend instead?
A clinic that answers these plainly is worth your time. Our pre-treatment checklist expands this list for visitors to Korea.
Bottom line
Vaginal stem cell therapy is unproven. It may offer some women a modest, temporary improvement in comfort or sensation, but the studies are too small and too weak to promise anything, and it cannot repair structural laxity or prolapse. Spend your money on a proper assessment first; the right treatment may turn out to be hormonal, surgical or nothing at all. Contact Somssi for an honest evaluation.
Private consultation
Talk it through with Dr. Yoon's team
English-speaking coordinators, a written treatment plan and a clear quote after your consultation. Same-day discharge for most procedures.
Mon, Tue, Wed, Fri, Sat 09:30–18:00 (KST). Closed Thu, Sun and holidays. 7F Sangkyung Building, 120 Teheran-ro, Gangnam-gu, Seoul.
Dr. Yoon Ho-joo, MD, PhD
OB/GYN specialist, Catholic University of Korea. Founder of Somssi Women's Clinic (2000). Published on female sexual function after reconstructive vaginal surgery; speaker at ESSM, ISSWSH, WAS and SMSNA.
Questions patients ask
Frequently asked questions
Short, honest answers. For anything personal, a consultation is the right place to ask.
Has any randomized controlled trial tested vaginal stem cell therapy?
There are a few small randomized trials of PRP for vaginal atrophy or incontinence, with mixed results and short follow-up, and essentially none of adequate size for cultured stem cells or exosomes in vaginal tissue. No trial large enough to settle the question has been published. Until that changes, the treatment remains investigational.
Why do clinics report such high satisfaction rates?
Satisfaction surveys from the clinic providing the treatment are not controlled studies. They capture expectation, the care experience and short-term change, and they rarely follow patients to the point where effects fade. High satisfaction figures from uncontrolled data are marketing, not proof.
If it is unproven, why do doctors offer it?
Some offer it because the mechanism is plausible and the risk with autologous products is low; some because demand is high. The ethical approach is to label it investigational, explain the evidence, avoid guarantees and offer proven alternatives. That is the standard Somssi holds itself to.
Could it work for me even if the studies are weak?
Possibly, in a modest and temporary way, especially for dryness or surface comfort. What it cannot do is change your anatomy. If your symptom is looseness, a bulge or a descended uterus, the answer is structural, and an injection will not help regardless of how the studies turn out.
What should I try before regenerative injections?
For dryness, vaginal moisturizers and local estrogen if appropriate. For mild laxity or leakage, supervised pelvic floor training. For sexual difficulty, a proper sexual-medicine assessment of hormones, medications, pain and relationship factors. For structural problems, a surgical opinion. These have far better evidence and are usually cheaper.
Keep reading
Related treatments and guides
- Vaginal Stem Cell Therapy — what regenerative options exist at Somssi and who they suit
- What Is Vaginal Stem Cell Therapy and How Does It Work? — the mechanism, product by product
- Is Vaginal Stem Cell Therapy Safe? — risks and Korean regulation
- Vaginal Stem Cell Therapy vs PRP: What Is the Difference? — why PRP has the stronger evidence base
- Who Is a Candidate for Vaginal Stem Cell Therapy? — when it is reasonable to try
- Vaginoplasty vs Non-Surgical Vaginal Tightening: Which Is Better? — the surgical comparison
Sources and medical review
- American College of Obstetricians and Gynecologists (ACOG), guidance on elective female genital cosmetic procedures and on treatment of genitourinary syndrome of menopause.
- US Food and Drug Administration (FDA), consumer warnings on unapproved stem cell, exosome and regenerative products.
- Yoon HJ. Perineal plastic surgery (colpoperineoplasty) and female sexual function. Korean Journal of Obstetrics and Gynecology. 2005;48(6).
- Te Linde's Operative Gynecology (textbook), chapters on pelvic support and posterior vaginal repair.
Next step
A consultation first. A decision only when you are ready.
Tell us what you are experiencing and what you hope to change. Dr. Yoon examines, measures and explains the options, including when no surgery is the right answer. International patients can start with an online consultation before travelling to Seoul.
